Enveric Biosciences (ENVB) Preferred Shares (2016 - 2020)
Enveric Biosciences (ENVB) posted Preferred Shares of $32754.0 for Q4 2020, up 670.86% sequentially from $4249.0 in Q3 2020, and up 1147.77% YoY from $2625.0 in Q1 2020.
Enveric Biosciences (ENVB) Preferred Shares (2016 - 2020) Analysis & Trends
Enveric Biosciences has reported Preferred Shares for 5 years, with the latest figure at $32754.0 in Q4 2020.
- Quarterly Preferred Shares rose 1147.77% year-over-year to $32754.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $32754.0 (up 1147.77% YoY) and the FY2020 annual result came in at $32754.0, up 1147.77% from the prior year.
- Preferred Shares advanced to $32754.0 in Q4 2020 per ENVB's latest filing, from $4249.0 in the prior quarter.
- Over five years, Preferred Shares peaked at $32754.0 in Q4 2020 and troughed at $2625.0 in Q4 2019.
- A 5-year average of $5660.9 and a median of $4186.0 in 2018 frame the typical range for Preferred Shares.
- The sharpest annual moves came in 2019 and 2020: Preferred Shares sank 37.6% in 2019, then soared 1147.77% in 2020.
- Over 5 years, Preferred Shares stood at $3636.0 in 2016, then increased by 11.5% to $4054.0 in 2017, then rose by 3.77% to $4207.0 in 2018, then tumbled by 37.6% to $2625.0 in 2019, then jumped by 1147.77% to $32754.0 in 2020.
- According to Business Quant data, Preferred Shares over the past three periods registered $32754.0, $4249.0, and $4249.0 for Q4 2020, Q3 2020, and Q2 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Enveric Biosciences | 5.66 Mn | -2.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 32,754.00 |
| Sep 30, 2020 | 4,249.00 |
| Jun 30, 2020 | 4,249.00 |
| Mar 31, 2020 | 4,249.00 |
| Dec 31, 2019 | 2,625.00 |
| Sep 30, 2019 | 4,249.00 |
| Jun 30, 2019 | 4,249.00 |
| Mar 31, 2019 | 4,207.00 |
| Dec 31, 2018 | 4,207.00 |
| Sep 30, 2018 | 4,186.00 |
| Jun 30, 2018 | 4,054.00 |
| Mar 31, 2018 | 4,054.00 |
| Dec 31, 2017 | 4,054.00 |
| Sep 30, 2017 | 3,840.00 |
| Jun 30, 2017 | 3,737.00 |
| Mar 31, 2017 | 3,636.00 |
| Dec 31, 2016 | 3,636.00 |